Is biocept a real company?

Is biocept a real company?

Biocept, Inc. is a commercial-stage cancer diagnostics company. The Company focuses on developing and commercialization proprietary circulating tumor cell and circulating tumor DNA tests.

Why is biocept stock so low?

Shares of Biocept Inc. BIOC, -2.20% plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock offering at a deep discount.

What is the biocept blood test?

Biocept is using a simple non-invasive blood test, sometimes referred to as a liquid biopsy, to help doctors and patients create more personalized, responsive treatment plans by tracking cancer in real time.

How many employees does biocept have?

Company Growth (employees)

Is biocept a good investment?

If you are looking for stocks with good return, Biocept Inc can be a profitable investment option. Biocept Inc quote is equal to 3.840 USD at 2021-11-09. With a 5-year investment, the revenue is expected to be around +130.71%. Your current $100 investment may be up to $230.71 in 2026.

Where is biocept?

The company’s new 39,000-square-foot headquarters, manufacturing and lab facility will be located at 9955 Mesa Rim Road, San Diego, CA 92121.

Is biocept a good buy?

Biocept has received a consensus rating of Buy.

Will Biocept go up?

Will Biocept stock price grow / rise / go up? Yes. The BIOC stock price can go up from 3.730 USD to 4.867 USD in one year.

Do you lose money with reverse split?

When a company completes a reverse stock split, each outstanding share of the company is converted into a fraction of a share. Investors may lose money as a result of fluctuations in trading prices following reverse stock splits.

What is liquid biopsy test?

Listen to pronunciation. (LIH-kwid BY-op-see) A test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or for pieces of DNA from tumor cells that are in the blood. A liquid biopsy may be used to help find cancer at an early stage.

How high does Biocept go?

Stock Price Forecast The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 12.00. The median estimate represents a +248.53% increase from the last price of 3.73.

Is Biocept worth buying?

Is Biocept a buy right now? 3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Biocept in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Biocept stock.

Who is the CEO of biocept, Inc?

SAN DIEGO, September 07, 2021–Biocept (Nasdaq: BIOC), a leading provider of molecular diagnostic assays and services, announces that Michael Nall, President and CEO, will present at four upcoming investor conferences as follows:

What kind of cancer is biocept used for?

Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company leverages its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer.

Where can I get a biocept license in the US?

Licenses and Certifications Biocept is fully approved, licensed and accredited by the states of California, Florida, Maryland, Pennsylvania and Rhode Island; CLIA, and Medicare/Medicaid and CAP. We strictly adhere to all HIPAA Policies and Procedures designed to prevent violations by our Company and our employees.

What kind of doctors use biocept liquid biopsies?

Biocept’s services are available to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Our liquid biopsies have been used by doctors in thousands of patient cases.